TGA Approval

VYNDAQEL tafamidis meglumine 20 mg soft gelatin capsule blister pack (316241)

ARTG ID

316241

ARTG Name

VYNDAQEL tafamidis meglumine 20 mg soft gelatin capsule blister pack

Sponsor

Pfizer Australia Pty Ltd

ARTG Date

March 16, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

PFIZER AUSTRALIA PTY LTD

Ingredient Name

tafamidis meglumine

Empowering clinical research with data-driven insights and AI-powered tools.

VYNDAQEL tafamidis meglumine 20 mg soft gelatin capsule blister pack (316241) - TGA 批准文号 | MedPath